| Measure Title: |
REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.
|
| Report Title: |
Health; Medicaid; Insurance; Ketamine Therapy; Auditor; Report
|
| Description: |
|
| Companion: |
SCR8
|
| Package: |
None
|
| Current Referral: |
HHS, WAM
|
| Introducer(s): |
FEVELLA
|
| Act: |
|
| Sort by Date | Chamber | Status Text |
| 3/24/2025 | S | The committee on HHS deferred the measure. |
| 3/20/2025 | S | The committee(s) on HHS has scheduled a public hearing on 03-24-25 1:05PM; Conference Room 225 & Videoconference. |
| 2/3/2025 | S | Referred to HHS, WAM. |
| 1/30/2025 | S | Offered. |
S = Senate |
H = House |
D = Data Systems |
$ = Appropriation measure |
ConAm = Constitutional Amendment
Some of the above items require Adobe Acrobat Reader. Please visit
Adobe's download page
for detailed instructions.
SR4